This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
Saul Centers(BFS) was downgraded to sell at TheStreet Ratings.
Allergan(NOK) was downgraded at Goldman Sachs. Valuation call, based on a $110 price target, Goldman said.
Big Lots(BIG) was downgraded to hold at TheStreet Ratings.
CH Robinson(CHRW) was downgraded at Goldman Sachs to sell from neutral. $56 price target. Light truck names should lag the broader group, Goldman said.
Facebook(FB - Get Report) was upgraded at UBS to buy from neutral. Price target goes to $30. Current valuation is low and new monetization efforts are encouraging, UBS said.
Forest Laboratories(FRX) was upgraded at Goldman Sachs to buy from neutral. $50 price target. See a higher potential for management to explore strategic options, Goldman said.
Fulton Financial(FULT) was downgraded at Credit Suisse to underperform from neutral. $9.50 price target. Expect negative revisions to mortgage banking estimates, Credit Suisse said.
Kimberly-Clark(KMB - Get Report) was upgraded at BMO Capital Markets to market perform from underperform. Valuation call, based on a $96 price target, BMO Capital Markets said.
Medicines Company(MDCO) was downgraded at Oppenheimer to perform from outperform. New analyst believes the stock is fully valued, Oppenheimer said.
Netgear(NTGR) was upgraded at Wedbush to outperform from neutral. $38 price target. Company has potential catalysts for the second half and 2014, Wedbush said.
Questcor(QCOR) was downgraded at Bank of America/Merrill Lynch to neutral from buy. $51 price target. Acthar could face increased competition, BofA/Merrill said.
Questcor was upgraded at Oppenheimer to outperform from perform. $57 price target. New analyst believes that Acthar can drive near-term growth, Oppenheimer said.
Southern Company(SO - Get Report) was upgraded at Citigroup to buy from neutral. The GP rate case will be manageable, and Vogtle cost overruns do not present a structural issue, Citi said.
SPX(SPW) was downgraded at Citigroup to sell from neutral. Price target is $68. There is significant second half earnings risk and valuation is elevated, Citigroup said.
Total System(TSS) was upgraded to outperform at Wells Fargo. Company shows unanticipated FCF growth and trades at a cheap multiple, Wells Fargo said.